Lauriane Goldwirt

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Development and Validation of Simultaneous Quantification of 6TGN and 6MMPN in Whole Blood Using LC-MS/MS: An Application to Therapeutic Drug Monitoring in Hematological Malignancies and in Inflammatory Bowel Diseases.

Development and Validation of Simultaneous Quantification of 6TGN and 6MMPN in Whole Blood Using LC-MS/MS: An Application to Therapeutic Drug Monitoring in Hematological Malignancies and in Inflammatory Bowel Diseases.

Journal: Biomedical chromatography : BMC

Published: April 21, 2026

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Journal: Leukemia

Published: April 12, 2026

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial.

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial.

Journal: BMJ open

Published: February 05, 2026

Development and Validation of a Simultaneous Quantification Method for 12 Targeted Therapies and 3 Active Metabolites in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry: An Application to Therapeutic Drug Monitoring in Patients With Hematological Malignancies.

Development and Validation of a Simultaneous Quantification Method for 12 Targeted Therapies and 3 Active Metabolites in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry: An Application to Therapeutic Drug Monitoring in Patients With Hematological Malignancies.

Journal: Therapeutic drug monitoring

Published: September 15, 2025

A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomized, Factorial, Noninferiority Trial.

A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomized, Factorial, Noninferiority Trial.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: September 01, 2025

Blood Never Lies: The PopPK-Based Lie Detector.

Blood Never Lies: The PopPK-Based Lie Detector.

Journal: Clinical pharmacokinetics

Published: August 28, 2025

Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors.

Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors.

Journal: HemaSphere

Published: July 25, 2025

Use of Ommaya Reservoirs in the management of acute leukemias in children and adolescents: Guidelines from the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE) Committee

Use of Ommaya Reservoirs in the management of acute leukemias in children and adolescents: Guidelines from the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE) Committee

Journal: Bulletin du cancer

Published: May 14, 2025

Continuous Intrathecal Infusion of Nivolumab in Advanced Melanoma With Concomitant Leptomeningeal Disease: Efficacy, Safety, and Pharmacokinetics.

Continuous Intrathecal Infusion of Nivolumab in Advanced Melanoma With Concomitant Leptomeningeal Disease: Efficacy, Safety, and Pharmacokinetics.

Journal: Neurosurgery

Published: January 07, 2025

Monocentric experience of venetoclax-based regimen in paediatric refractory and relapsed AML/MDS.

Monocentric experience of venetoclax-based regimen in paediatric refractory and relapsed AML/MDS.

Journal: British journal of haematology

Published: July 22, 2024

DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy.

DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy.

Journal: Cancer chemotherapy and pharmacology

Published: July 22, 2024

Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia.

Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia.

Journal: Haematologica

Published: June 20, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026